Literature DB >> 2070279

Elevated serum levels of creatine kinase BB in autosomal dominant osteopetrosis type II.

J Gram1, S Antonsen, M Hørder, J Bollerslev.   

Abstract

Serum levels of creatine kinase isoenzyme BB (CK-BB) were measured spectrophotometrically and by electrophoresis in 17 patients with autosomal dominant osteopetrosis (ADO) and compared with those of age- and sex-matched controls. Eight patients had ADO type 1 and nine patients had ADO type II. CK-BB was significantly increased (p less than 0.002) in type II but normal in type I compared with controls. This finding supports heterogeneity of ADO, and it may indicate a potential role for CK-BB as a marker of immature osteoclasts.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2070279     DOI: 10.1007/BF02556458

Source DB:  PubMed          Journal:  Calcif Tissue Int        ISSN: 0171-967X            Impact factor:   4.333


  10 in total

1.  Recommended method for the determination of creatine kinase in blood modified by the inclusion of EDTA. The Committee on Enzymes of the Scandinavian Society for Clinical Chemistry and Clinical Physiology (SCE).

Authors:  M Hørder; E Magid; E Pitkänen; M Härkönen; J H Strömme; L Theodorsen; W Gerhardt; J Waldenström
Journal:  Scand J Clin Lab Invest       Date:  1979-02       Impact factor: 1.713

Review 2.  Autosomal dominant osteopetrosis: bone metabolism and epidemiological, clinical, and hormonal aspects.

Authors:  J Bollerslev
Journal:  Endocr Rev       Date:  1989-02       Impact factor: 19.871

3.  Elevated levels of creatine kinase BB isoenzyme in three patients with adult osteopetrosis.

Authors:  T Yoneyama; H L Fowler; J W Pendleton; P P Sforza; C Y Lui; A Iranmanesh; R D Gerard
Journal:  N Engl J Med       Date:  1989-05-11       Impact factor: 91.245

4.  Immunochemical determination of CK-MB isoenzyme in human serum. II. An enzymic approach.

Authors:  R Wicks; M Usategui-Gomez; M Miller; M Warshaw
Journal:  Clin Chem       Date:  1982-01       Impact factor: 8.327

5.  Structural and histomorphometric studies of iliac crest trabecular and cortical bone in autosomal dominant osteopetrosis: a study of two radiological types.

Authors:  J Bollerslev; T Steiniche; F Melsen; L Mosekilde
Journal:  Bone       Date:  1989       Impact factor: 4.398

6.  Heterogeneity of autosomal dominant osteopetrosis.

Authors:  P E Andersen; J Bollerslev
Journal:  Radiology       Date:  1987-07       Impact factor: 11.105

7.  Creatine kinase brain isoenzyme in infantile osteopetrosis.

Authors:  Y Hiroyama; T Miike; S Sugino; K Taku
Journal:  Pediatr Neurol       Date:  1987 Jan-Feb       Impact factor: 3.372

8.  Osteopetrosis in the toothless rat: failure of osteoclast differentiation and function.

Authors:  L K Osier; S N Popoff; S C Marks
Journal:  Bone Miner       Date:  1987-10

9.  Macro creatine kinases: results of isoenzyme electrophoresis and differentiation of the immunoglobulin-bound type by radioassay.

Authors:  J Bohner; W Stein; R Steinhart; U Würzburg; M Eggstein
Journal:  Clin Chem       Date:  1982-04       Impact factor: 8.327

10.  Osteopetrosis. A genetic and epidemiological study.

Authors:  J Bollerslev
Journal:  Clin Genet       Date:  1987-02       Impact factor: 4.438

  10 in total
  7 in total

1.  Osteoclasts from patients with autosomal dominant osteopetrosis type I caused by a T253I mutation in low-density lipoprotein receptor-related protein 5 are normal in vitro, but have decreased resorption capacity in vivo.

Authors:  Kim Henriksen; Jeppe Gram; Pernille Høegh-Andersen; Rune Jemtland; Thor Ueland; Morten H Dziegiel; Sophie Schaller; Jens Bollerslev; Morten A Karsdal
Journal:  Am J Pathol       Date:  2005-11       Impact factor: 4.307

2.  RANKL up-regulates brain-type creatine kinase via poly(ADP-ribose) polymerase-1 during osteoclastogenesis.

Authors:  Jianfeng Chen; Yong Sun; Xia Mao; Qizhan Liu; Hui Wu; Yabing Chen
Journal:  J Biol Chem       Date:  2010-09-13       Impact factor: 5.157

3.  Serum creatine kinase isoenzymes in children with osteogenesis imperfecta.

Authors:  P D'Eufemia; R Finocchiaro; A Zambrano; V Lodato; L Celli; S Finocchiaro; P Persiani; A Turchetti; M Celli
Journal:  Osteoporos Int       Date:  2016-08-25       Impact factor: 4.507

Review 4.  Advances in osteoclast biology resulting from the study of osteopetrotic mutations.

Authors:  T Segovia-Silvestre; A V Neutzsky-Wulff; M G Sorensen; C Christiansen; J Bollerslev; M A Karsdal; K Henriksen
Journal:  Hum Genet       Date:  2008-11-06       Impact factor: 4.132

5.  Characterization of osteoclasts from patients harboring a G215R mutation in ClC-7 causing autosomal dominant osteopetrosis type II.

Authors:  Kim Henriksen; Jeppe Gram; Sophie Schaller; Bjarne H Dahl; Morten H Dziegiel; Jens Bollerslev; Morten A Karsdal
Journal:  Am J Pathol       Date:  2004-05       Impact factor: 4.307

6.  Osteopetrosis, hypophosphatemia, and phosphaturia in a young man: a case presentation and differential diagnosis.

Authors:  Zahi Mitri; Vin Tangpricha
Journal:  Case Rep Endocrinol       Date:  2012-02-09

7.  Dissociation of bone resorption and bone formation in adult mice with a non-functional V-ATPase in osteoclasts leads to increased bone strength.

Authors:  Kim Henriksen; Carmen Flores; Jesper S Thomsen; Anne-Marie Brüel; Christian S Thudium; Anita V Neutzsky-Wulff; Geerling E J Langenbach; Natalie Sims; Maria Askmyr; Thomas J Martin; Vincent Everts; Morten A Karsdal; Johan Richter
Journal:  PLoS One       Date:  2011-11-07       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.